Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis
dc.contributor.author | Spite, M | en_US |
dc.contributor.author | Norling, LV | en_US |
dc.contributor.author | Summers, L | en_US |
dc.contributor.author | Yang, R | en_US |
dc.contributor.author | Cooper, D | en_US |
dc.contributor.author | Petasis, NA | en_US |
dc.contributor.author | Flower, RJ | en_US |
dc.contributor.author | Perretti, M | en_US |
dc.contributor.author | Serhan, CN | en_US |
dc.date.accessioned | 2017-02-03T12:20:06Z | |
dc.date.available | 2009-09-21 | en_US |
dc.date.issued | 2009-10-29 | en_US |
dc.date.submitted | 2017-01-30T09:44:10.750Z | |
dc.identifier.issn | 0028-0836 | en_US |
dc.identifier.uri | http://qmro.qmul.ac.uk/xmlui/handle/123456789/19168 | |
dc.description.sponsorship | National Institutes of Health grants GM-38765 and P50-DE016191 (C.N.S.), Welcome Trust Programme grant 086867/Z/08/Z (R.J.F. and M.P.) and Project grant 085903/Z/08 (R.J.F.) and Arthritis Research Campaign UK fellowships 18445 and 18103 (to L.V.N. and D.C., respectively). M.S. received a National Research Service Award from the NHLBI (HL087526). | en_US |
dc.format.extent | 1287 - U125 | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartof | NATURE | en_US |
dc.subject | NITRIC-OXIDE | en_US |
dc.subject | LIPID MEDIATORS | en_US |
dc.subject | ACUTE-INFLAMMATION | en_US |
dc.subject | ENDOTOXIC-SHOCK | en_US |
dc.subject | IN-VIVO | en_US |
dc.subject | MACROPHAGES | en_US |
dc.subject | ACTIVATION | en_US |
dc.subject | RESOLUTION | en_US |
dc.subject | RECEPTORS | en_US |
dc.subject | MORTALITY | en_US |
dc.title | Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis | en_US |
dc.type | Article | |
dc.identifier.doi | 10.1038/nature08541 | en_US |
pubs.issue | 7268 | en_US |
pubs.notes | Not known | en_US |
pubs.volume | 461 | en_US |
qmul.funder | The patho-physiology of the ALX receptor in inflammation::Wellcome Trust | en_US |